International Conference on
Pharmaceutical and Pharma Industry

Julie received her BSc(Hons) in Chemistry from University College Cork in 2004, then began her career as a Senior QC Analyst at Pfizer. She subsequently worked for an electrochemical start-up "Anzode" in New Zealand and as an analytical chemist for Colorcon before moving into investment banking, where she used her experience managing projects to perform Execution Management at CIBC for 5 years. Julie then returned to science, obtaining an MSc in Drug Design from University College London, where she earned the Dean's Prize for her dissertation on repositioning drugs to treat malaria. She became a member of the OICR Drug Discovery team in 2017, working as a computational chemist, specifically virtual screening, providing structural insights to binding, generating homology models of proteins as well as database management for various projects. Julie has been working as a Senior Scientist on the Drug Discovery team at Cyclica since August, 2020, where she applies Cyclica's technology to drug discovery projects. Today's talk will provide an overview of Cyclica's MatchMaker technology and how Julie used Matchmaker to design a novel inhibitor for DCAF1, resulting in the first co-crystal structure of DCAF1 with a ligand to be deposited in the PDB.

Drug Discovery

Russell Elliott, Ph.D., has served as the Vice President of Drug Development since May 2016. Dr. Elliott has over 25 years of industry experience, previously holding positions as Head of Skincare Technology at Lonza Inc. from 2015 to 2016, Head of Product Development at Stiefel (a GSK Company) from 2011 to 2014, Head of the Center of Excellence for Liquids, Cream and Ointments at GSK (UK) from 2007 to 2011, and Principal Scientist at Procter & Gamble from 1992 to 2007. He has filed more than 60 patent applications in the area of skincare formulation. Dr. Elliott has a PhD and MA from The University of Oxford and is a Fellow of the Royal Society of Chemistry

Drug development

Dr. Firoj A. Tamboli is right now an Associate Teacher and HOD in the Branch of Pharmacognosy, Bharati Vidyapeeth School of Drug store, Kolhapur, India. From Shivaji University in Kolhapur, Maharashtra, India, he earned the highest degree, the Ph.D., in pharmacy. He has published two chapters, one book, 51 abstracts, 47 articles, and one book.

Biomedical Sciences, Natural Products, Pharmacy, Phytochemicals, Herbal Medicine.

Prof. Dr. Heyam Saad Ali, Ph-D –She is working in the pharmaceutics department in Dubai Pharmacy College, UAE. Prof. contributed more than 70 articles to reputed international scientific journals and conferences, in different conventional, controlled and targeted drug delivery systems in pharmaceutical product development. She has been invited as a speaker at numerous International conferences. Reviewer and member of the editorial board of many international journals.

Pharmaceutics

Dr. Wagner is full professor of Pharmaceutical Biotechnology at LMU since 2001 and member of the Munich Center for Nanoscience. He coordinates ‘Biomedical Nanotechnologies’ of the Excellence Cluster NIM. After a PhD from TU Vienna and postdoc at ETH Zürich, he was Group Leader at the IMP Vienna (1987-1995) and Director for Cancer Vaccines at BoehringerIngelheim Austria (1992-2001). Dr. Wagner has authored >403 publications (h-index 72). He is Board member of the German Society for Gene Therapy, Committee member of ASGCT, and BSA member of CRS. He is Editor of Pharmaceutical Research and Editor-in-Chief of The Journal of Gene Medicine.

Pharmaceutical Sciences, Medicine

Grazyna Biala, full professor of the pharmaceutical sciences; Head of the Chair and Department of Pharmacology with Pharmacodynamics, Medical University of Lublin, Poland, Dean of the Faculty of Pharmacy. Recipient of seven fellowships of French and Polish Government; in total 5 years of training and regular post in Paris; 11 Erasmus Plus training at the European Faculties of Pharmacy. Author of 390 papers (150 original), if=301,5; tutor of 12 doctoral thesis, citation index=27; principle investigator of polish and international (”Polonium” and Visegrad Found) grants and UE projects (e.g., High Quality Medical Education). Member of the Polish Academy of Science Committee for Physiological and Pharmacological Sciences. Place on the list in the World's TOP 2% Scientists ranking containing the names of researchers whose publications are most often cited organized by Stanford University, and in the ranking of the best cited scientists according to Elsevier; 4 times scientific awards of the Minister of Health, the award of Jędrzej Śniadecki of the 5th Faculty of Medical Sciences of the Polish Academy of Sciences; Medal of the Mayor of the city Lublin for outstanding achievements in the field of pharmaceutical sciences and many years of teaching and research activity, Medal of the Medical University of Lublin for contributing to the good name of the University and outstanding contribution to scientific development. Invitations for giving lectures in Polish, English and French. Significant scientific, teaching and organizational experience in the field of experimental pharmacology, neuropsychopharmacology, pharmacotherapy and neurobiology, especially in the context of research on the central nervous system and neuropsychiatric disorders. Scientific works focused on behavioral research on the participation of various neurotransmitter systems in the action of addictive substances. Main topics include: central effects of psychoactive compounds, anxiety, stress, memory and learning, depression, Parkinson's and Alzheimer's disease, dementia, psychosis, the reinforcing effects of drugs, molecular mechanisms common to addiction and memory processes (e.g., the influence of the endocannabinoid and cholinergic systems, calcium homeostasis and kinase/phosphatase balance) and neuropsychiatric disorders and further strategies for their pharmacotherapy; pharmacological screening of newly synthesized compounds and natural products isolated from plants.

Pharmaceutical Sciences

Doctor In Pharmacy and extraordinary Price. Graduate in Medicine and Surgery Univ. Madrid. Courses in France. Humboldt Researcher in Germany Head Area of Toxicology in Health Ministry and professor in various Faculties. Invited Professor in the Clinical Chemistry Department, Connecticut University, USA. Expert of the European Unión (E-44.386-N) Research projects and Grants (CSIC-Spain and CNPq-Brasil), European Community, Hahn Meitner Institute Berlin, and utilization great installations of the E.U. Lecturer in diverse Research institutions: Paris, Lyon; Strasbourg, Connecticut, Munich; Botucatu, Araraquara and Bauru, Brazil, Taiwan; Italy. Academician of numerous Academies in Perú; Bulgaria, and Spain. Brazil and Argentina. Diverse prices. Published more than 200 articles, 10 book chapters, and more than 100 Congress Communications. Delegate to WHO, OCDE and others. Treasurer and General Secretary of the Royal National Academy of Pharmacy of Spain.

Clinical Chemistry, Pharmaceutical Science

Richard Denk is working at the company SKAN AG, headquartered in Allschwil in the position Senior Consultant Aseptic Processing & Containment. Richard is member of the PDA Isolator Expert Group and publisher of the PDA Paper “Isolator Surfaces and Contamination Risk to Personnel and Patient”. Furthermore, Richard is Member of the ISO TC 198 WG-9 Aseptic Isolator Group. Richard was on the Annex 1 and PIC/s Annex 2 commenting team of the ISPE, Richard founded 12 years ago the Containment expert group of the ISPE D / A / CH. The Containment Group published the Containment Manual Richard was responsible for in September 2015. Richard has spent more than 20 years with the subject on Aseptic Processing and highly active / highly hazardous substances and has developed the containment pyramid.

Pharmaceutics

Thomas J. Webster’s (H index: 115; Google Scholar) degrees are in chemical engineering from the University of Pittsburgh (B.S., 1995; USA) and in biomedical engineering from RPI (Ph.D., 2000; USA). He has served as a professor at Purdue (2000-2005), Brown (2005-2012), and Northeastern (2012-2021; serving as Chemical Engineering Department Chair from 2012 - 2019) Universities and has formed over a dozen companies that have numerous FDA approved medical products currently improving human health. He is currently helping those companies and serves as a professor at Hebei University of Technology, Saveetha University, Vellore Institute of Technology, UFPI, and others. Dr. Webster has numerous awards including: 2020, World Top 2% Scientist by Citations (PLOS); 2020, SCOPUS Highly Cited Research (Top 1% Materials Science and Mixed Fields); 2021, Clarivate Top 0.1% Most Influential Researchers (Pharmacology and Toxicology); 2022, Best Materials Science Scientist by Citations (Research.com); and is a fellow of over 8 societies. Prof. Webster is a former President of the U.S. Society For Biomaterials and has over 1,350 publications to his credit with over 53,000 citations. He was recently nominated for the Noble Prize in Chemistry (2023).

Chemistry, Biopharmaceutical

He is a professor of Microbiology and Immunology from Stanford University School of Medicine. He was born in the USA and completed his Ph.D. in the year 1969 in the field of microbiology from the University of California, Los Angeles. He is having teaching knowledge of around 55 years. He is an active member of many microbiological and immunological societies and associations. He received the Fulbright Scholar award in the year 1964-1971. He is the author of 142 publications along with a few patents. He has been a part of many scientific conferences during his teaching and educational career. He had received funding from a reputed organization for his research work. His current research interest includes immunology, Microbiology, Cancer, Genetics studies, etc. Currently, he is working on Exosome (EV) project and also on the Extension of the ongoing antibiotic work.

Microbiology, Cancer

Andreia Freitas studied Chemistry at the Instituto Superior Técnico (IST), Lisbon, and graduated an MS, in Analytical Chemistry (2008) at the same institution. She received her PhD degree in Pharmaceutical Sciences (2015), a specialty in Bromatology and Hydrology at the Faculty of Pharmacy, University of Coimbra. With more than 18 years of experience, she is currently a researcher in the field of Food Safety specially in the area of veterinary drug residues analysis and contaminants in food of animal origin in the Nacional Institute of Agrarian and Veterinary Research (INIAV) in the National Reference Laboratory for Food Safety.

Veterinary, Biochemistry

Dr. Niranjan Koirala, Nepal born researcher earned his Ph.D. from South Korea (2016) and Postdoctoral fellowships from UNAM, Mexico (2018) and UM, Macau SAR (2020). His interest is in the field of pharmaceutical engineering, pharmaceutical/medicinal chemistry, natural products drugs discovery, secondary metabolites, flavonoids, diabetes, antibiotics and anti-cancer agents. He is the recipient of Nepal Bidhya Bhushan “A” award from the honorable President of Nepal, young scientist award, best PhD thesis gold medal award, best oral presentations, best poster presentations and several other research accolades. He has published above 35 original articles in reputed peer-reviewed journals and holds 4 Korean patents. He has a cumulative impact factor of 75, global citations of 700 and h-index 14 as of 2020. He is serving in several national and International indexed journals as the journal editor and editorial board member.

Antibiotics, Medicine

Dr. Fuhr has 30+ years of experience in teaching and research. He is Professor of Economics at Widener University. Dr. Fuhr’s primary research areas are antitrust, health economics, pharmacoeconomics, telecommunications, and sports economics. He has published over forty journal articles. In health care, he has written on hospital mergers, exclusive arrangements, health insurance, bundling and doctor’s fees. In pharmacoeconomics, Dr. Fuhr has written on cost benefit analysis and predictive modeling. Dr. Fuhr’s primary research areas are antitrust, health economics, pharmacoeconomics, telecommunications, and sports economics.

Pharmacoeconomics

PhD (Specialist in Genetic Toxicology; Univ. Autónoma de Barcelona) and Bachelor of Pharmacy (Univ. Central de las Villas, Cuba). Current position: Senior Toxicologist & Nonclinical Safety Adviser, at Ferrer Advanced Biotherapeutics. Ferrer Internacional. Previous positions: Pharmacovigilance Officer/Senior Nonclinical Toxicologist (Ferrer); Medical Adviser. Dermatology Area (Ferrer); Senior Toxicologist. Head of In vivo Toxicology Group (Ferrer); Senior Nonclinical Toxicology Study Director (RCC-CIDA s.a.l.). Senior Toxicologist/Nonclinical Safety with more than 15 years of experience working in the design and management of several fields of nonclinical toxicology and safety issues to support the efficacy/safety in the R&D in New Development Projects with the aim to obtain new medicinal products. Co-author of over 12 peer-review of scientific publications. Invited Speaker at 20 Scientific Events in the last 10 years at international congress. Expert of European Commission: Sixth and Seven Framework Programme. Area Preclinical Toxicology and Mutagenesis. Expert Member Panel in Innovative Medicines Initiative (IMI)-Scientific Panel to evaluate the proposals for the IMI2 9th Call: topic on ‘Next generation of electronic translational safety–NexGETS. Member of Editorial Board of scientific journals and several Organizing Committee of Scientific Congress. Member of Jury several doctoral theses (Univ. Autónoma de Barcelona. Current interests: Open innovation & Collaborative Bio-Research. Advanced Therapies. Neuropharmacology. Ophthalmology. Molecular diagnostics and other Therapeutic areas.

Neuropharmacology. Ophthalmology

Baruch Barzel is an associate professor at the mathematics department and the Gonda Multidisciplinary Brain Research Center of Bar-Ilan University. He completed his Ph.D. in physics at the Hebrew University of Jerusalem, and his postdoctoral training at the Network Science Institute of Northeastern University, Boston.

Biophysics

Amgad Rabie is the editor-in-chief & the chairman of the peer-reviewing committee of the famous & reputable journal in pharmaceutical sciences & researches worldwide, International Journal of Pharma Sciences and Scientific Research (IJPSR), USA, Canada, Europe, Asia, Egypt, Australia, and Brazil. He is also a editorial board director & chairman of the multidisciplinary and internationally famous & comprehensive journal in all pharmaceutical & medicinal sciences worldwide, Journal of Pharmaceutical and Medicinal Research (JPMR) (ISSN: 2455-0280).

Drug Discovery

COORDINATOR OF THE POSTGRADUATE COURSE IN AESTHETIC HEALTHCOORDINATOR OF THE POSTGRADUATE COURSE IN AESTHETIC HEALTH INTEGRATED SCHOOLS TIRADENTES - FITS - MACEIÓ, Faculty of Pharmaceutical Sciences of Ribeirão Preto - USP

Pharmaceutical Sciences

Prof. Dr. Alireza Heidari, Ph.D., D.Sc. is a Full Distinguished Professor and Academic Tenure of Chemistry and also Enrico Fermi Distinguished Chair in Molecular Spectroscopy at California South University (CSU), Irvine, California, USA. He has got his Ph.D. and D.Sc. degrees from California South University (CSU), Irvine, California, USA. Furthermore, he has double postdocs in Project Management, Oncology, Human Cancer Tissues and Synchrotron Radiation from Monash University, Melbourne, Victoria, Australia and also in Nanochemistry and Modern Molecular Electronic–Structure Computations Theory from California South University (CSU), Irvine, California, USA. His research interests include Biophysical Chemistry, Biomolecular and Biomedical Spectroscopy, Quantum Chemistry, Nanochemistry, Modern Electronic Structure Computations, Theoretical Chemistry, Mathematical Chemistry, Computational Chemistry, Vibrational Spectroscopy, Molecular Modelling, Ab initio & Density Functional Methods, Molecular Structure, Biochemistry, Molecular Simulation, Pharmaceutical Chemistry, Medicinal Chemistry, Oncology, Synchrotron Radiation, Synchrocyclotron Radiation, LASER, Anti–Cancer Nano Drugs, Nano Drugs Delivery, ATR–FTIR Spectroscopy, Raman Spectroscopy, Intelligent Molecules, Molecular Dynamics, Biosensors, Biomarkers, Molecular Diagnostics, Numerical Chemistry, Nucleic Acids, DNA/RNA Monitoring, DNA/RNA Hypermethylation & Hypomethylation, Human Cancer Tissues, Human Cancer Cells, Tumors, Cancer Tissues, Cancer Cells, etc. He has participated at more than seven hundred reputed international conferences, seminars, webinars, congresses, summits, meetings, symposiums and forums around the world as yet. Also, he possesses many published articles in Science Citation Index (SCI)/International Scientific Indexing (ISI), Medline/PubMed and Scopus Journals. It should be noted that he has visited many universities or scientific and academic research institutes in different countries such as United States, United Kingdom, Canada, Australia, New Zealand, Scotland, Ireland, Netherlands, Belgium, Denmark, Luxembourg, Romania, Greece, Russia, Estonia, Ukraine, Turkey, France, Swiss, Germany, Sweden, Norway, Italy, Austria, Czech Republic, Hungary, Poland, South Africa, Egypt, Brazil, Spain, Portugal, Mexico, Japan, Singapore, Malaysia, Indonesia, Thailand, Taiwan, Hong Kong, Philippines, South Korea, China, India, Kingdom of Saudi Arabia, Jordan, Qatar, United Arab Emirates, etc. as research fellow, sabbatical and volunteer researcher or visitor and so on heretofore. He has a history of several years of teaching for college students and various disciplines and trends in different universities. Moreover, he has been a senior advisor in various industries and factories. He is expert in many computer programs and programming languages. Hitherto, he has authored more than twenty books and book chapters in different fields of Chemistry. Syne, he has been awarded more than one thousand reputed 2 international awards, prizes, scholarships and honors. Heretofore, he has multiple editorial duties in many reputed international and peer–reviewed journals, books and publishers. Hitherward, he is a member of more than seven hundred reputed international academic–scientific–research institutes around the world. It should be noted that he is currently board member of the World Association of Theoretical and Computational Chemists (WATOC), member of the American Association for Cancer Research (AACR), Philadelphia, Pennsylvania, USA, member of the American Society for Biochemistry and Molecular Biology (ASBMB), Rockville, Maryland, USA, the President of the American International Standards Institute (AISI), Irvine, California, USA and also Head of Cancer Research Institute (CRI) and Director of the BioSpectroscopy Core Research Laboratory (BCRL) at California South University (CSU), Irvine, California, USA.

Biophysical Chemistry, Biomolecular and Biomedical Spectroscopy, Quantum Chemistry, Nanochemistry, Modern Electronic Structure Computations, Theoretical Chemistry, Mathematical Chemistry, Computational Chemistry, Vibrational Spectroscopy, Molecular Modelling, Ab initio & Density Functional Methods, Molecular Structure, Biochemistry, Molecular Simulation, Pharmaceutical Chemistry, Medicinal Chemistry, Oncology, Synchrotron Radiation, Synchrocyclotron Radiation, LASER, Anti–Cancer Nano Drugs, Nano Drugs Delivery, ATR–FTIR Spectroscopy, Raman Spectroscopy, Intelligent Molecules, Molecular Dynamics, Biosensors, Biomarkers, Molecular Diagnostics, Numerical Chemistry, Nucleic Acids, DNA/RNA Monitoring, DNA/RNA Hypermethylation & Hypomethylation, Human Cancer Tissues, Human Cancer Cells, Tumors, Cancer Tissues, Cancer Cells, etc.

Dr. Abdel Nasser Badawi Ibrahim Singab is currently working as Professor in Department of Pharmacognosy and also Deanat Faculty of Pharmacy, Ain Shams University, Abbassia, Cairo, Egypt. He has completed his Ph.D. in Pharmacognosy from Al-Azhar University, Cairo, Egypt in 1996. In past he worked as Lecturer/Assistant Professor/Associate Professor/Professor/ Vice-Dean in various Institutions. He is member of different associations such as Appeals Committee and the Patent Office Oppositions Academy of Scientific Research, Committee on Drug Pricing at the Ministry of Health, Committee on Upgrades Junior Faculty and Professors in Pharmacognosy and Phytochemistry at the Supreme Council Universities, Committee on Upgrades Junior Faculty and Professors in Pharmacology at Al-Azhar University, Equalization theses of the Supreme Council of Universities, Equalization bachelors degree in Pharmacy at the Ministry of Health in Egypt, the Supreme Council for the sector Universities, emanating-up inspection of the Sector Committee on the regulation of private Universities, and University council of Heliopolis University. His area of research focused on Botanical Investigation of Medicinal Plants, Isolation and Structural Elucidation of new Flavonoids, Iridals, Saponins, Sesquiterpene and Coumarin etc. He also supervised number of graduate students. He also actively participated in number of conferences. He is also working as member of following scientific societies, The Japanese Society of Pharmacognosy, Association of the Colleges of Pharmacy in the Arab World, Member of CIQAP Project from Ministry of Higher Education in Egypt, and Executive Committee of the Scientific Association of Colleges of Pharmacy in the Arab World. He has published 71 articles in journals as author/co-author.

Pharmacology and Toxicology Medicinal Plants Drug Discovery